How to Buy Crinetics Pharmaceuticals Stock
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors.
Crinetics Pharmaceuticals stock last closed at $30.15, down 0.89% from the previous day, and has decreased 30.59% in one year. It has overperformed other stocks in the Biotechnology industry by 0.47 percentage points. Crinetics Pharmaceuticals stock is currently +25.1% from its 52-week low of $24.10, and -51.78% from its 52-week high of $62.53.
At the moment, there are 93.05M CRNX shares outstanding. The market value of CRNX is $2.81B. In the past 24 hours, 665,815 CRNX shares were traded.
How to Buy Crinetics Pharmaceuticals Stock
Not sure how to invest in Crinetics Pharmaceuticals stock? Here's how.
- Figure out where to buy Crinetics Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Crinetics Pharmaceuticals stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Pick your payment method and add your information.
- Evaluate Crinetics Pharmaceuticals stock: The Crinetics Pharmaceuticals ticker symbol is CRNX. Is Crinetics Pharmaceuticals stock a good investment? Should you buy shares of CRNX? How do CRNX's underlying business fundamentals look? Do top analysts think Crinetics Pharmaceuticals is a good buy? Why has CRNX's stock price moved recently? (Hint: Our stock market research tools can help you figure out if CRNX is a good stock to buy).
- Make your CRNX buy order: Decide if you will purchase CRNX shares at the current market price or use a limit order to purchase CRNX stock at a specific price.
- Get the latest news on your CRNX position: Create a watchlist to keep track of your investment in Crinetics Pharmaceuticals stock.
Step 1: Figure out where to buy Crinetics Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy CRNX shares.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected your brokerage, you need to fill out some personal details so you can buy CRNX today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start your new brokerage account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on the best stock trading app, you need to deposit funds:
Watch the video below if you need help transferring money into your new investment account.
Step 4: Evaluate Crinetics Pharmaceuticals stock
Once you have decided on the best place to buy Crinetics Pharmaceuticals stock, it's very important to evaluate their stock before you invest, so you truly comprehend the risk as well as the opportunity.
Crinetics Pharmaceuticals shares quick numbers
Crinetics Pharmaceuticals Fundamentals
WallStreetZen was designed to help average investors do better fundamental analysis in less time.
You can see all of the due diligence checks on CRNX's stock page.
How is CRNX stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge CRNX's true value.
Using relative valuations measures:
- CRNX could be undervalued based on its P/B ratio of 2.12x, relative to Biotechnology industry P/B ratio of 4.04x
You can do more valuation research on CRNX's stock here.
How do CRNX Financials look?
Positive Financial Indicators:
- CRNX has a low debt to equity ratio of 0.08.
- There are more short-term assets than short-term liabilities on the CRNX balance sheet.
- There are more short-term assets than long-term liabilities on the CRNX balance sheet.
- CRNX has cash burn of 229814000. It has sufficient cash and short-term investments to cover this for at least one year.
- Total CRNX debt is lower than 5 years ago, relative to shareholder equity.
- CRNX has $1.35B in cash and short term investments. This is sufficient to cover its annual cash burn of $229.81M.
Negative Financial Indicators:
- CRNX profit margin has gone down from -5,345.9% to -28,720.7% in the past year.
Do analysts think it's a good time to buy CRNX stock
Out of 5 Equities analysts who track CRNX, the consensus analyst rating on Crinetics Pharmaceuticals is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Crinetics Pharmaceuticals stock forecast page.
CRNX Momentum
CRNX Performance Numbers
Last year, CRNX revenue was $1.04M. Over the past five year, CRNX's revenue has increased by -2.73% per year. This was slower than the Biotechnology industry average of 44.31%.
Learn more about CRNX's earnings and revenue performance here.
Are CRNX executives and large shareholders buying or selling the stock?
Over the last year, insiders at CRNX have bought more shares than they have sold.
Richard Scott Struthers, President CEO of CRNX, was the latest CRNX insider to buy. They bought $155,225.70 worth of CRNX stock on Apr 2, 2025.
Dig into more about who owns CRNX stock here.
Can I get consistent income from CRNX stock?
No, Crinetics Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your CRNX buy order
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally the easiest way to buy. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.
Press the Open button and your broker will place your order.
If you want more help with investing in stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your CRNX position
Now that you own some CRNX stock, you'll want to keep up with your company.
Add CRNX to a watchlist to get notified of important updates regarding your CRNX stock.
CRNX Feed
How to Buy Stock in Crinetics Pharmaceuticals
To summarize, here are the 6 steps to buy Crinetics Pharmaceuticals stock:
- Figure out where to buy Crinetics Pharmaceuticals stock
- Open a brokerage account
- Deposit funds into your investment account
- Evaluate Crinetics Pharmaceuticals stock
- Make your CRNX buy order
- Get the latest news on your CRNX position
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to get updates on your investment in Crinetics Pharmaceuticals, add CRNX to your watchlist below.
More Content You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.